Many of us take the ability to make babies for granted and yet know that for some prospective parents and babies, ...

In guidelines issued by the American Society of Clinical Oncology and published online Dec. 11 in the Journal of Clinical ...

He was cast as a real-life Dr Frankenstein, a scientist whose ego had led him to tamper with human life. After more than a hundred Chinese scientists issued a statement condemning his experiment, ...

The social media star, 32, announced on Tuesday that she is expecting another baby with her husband Mathew, following a ...

Eve was one of dozens of Thai women who traveled 4,000 miles — only to be trapped by the dark side of the global fertility ...

They were astonished to find where the fetus was growing.

Presentation Title: The ADELA study: A Double-blind, Placebo-controlled, Randomized Phase 3 Trial of Elacestrant (ELA)+ Everolimus (EVE) Versus ELA + Placebo (PBO) in ER+/HER2-Advanced Breast Cancer ...

In an era where lifestyle changes are rewriting the rules of family planning, Dr. Shweta Agarwal's Aansh IVF in Chandrapur ...

Expanded indication for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine ...

KOMZIFTI (ziftomenib), the first and only once-daily oral menin inhibitor for adult patients with R/R AML with a susceptible NPM1 mutation who have no satisfactory alternative treatment options, has ...

In addition to meeting the primary endpoint of non-inferiority for overall response rate (ORR) in the BRUIN CLL-314 study, pirtobrutinib achieved a numerically higher ORR of 87.0% compared to 78.5% ...